J. Rubio

J. Rubio graduated from the University of Valencia, Spain, in 1992. He completed his basic surgical training at Hospital de Sant Pau in Barcelone, Spain, and entered urological training in 1994 at the Puigvert Foundation. In 1998, he obtained his degree in urology from the University Autonoma of Barcelone, and spent one year at the University of Newcastle, UK, within the ESUP programme. In 1999, he obtained the Ph.D. degree in medicine from the University of Valencia on renal cell carcinoma. During that time, he joined Instituto Valenciano of Oncology (IVO) as a staff member and consolidated his clinical and research interest in uro-oncology. In 2002, he performed a fellowship in urolaparoscopy at Institute Montsouri in Paris, France. In 2005, he was appointed as a Clinical Chief within the Urology Service of IVO.

Biography Updated on 30 April 2008

Articles in Scholarly Journals [Incomplete List]

  1. Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder
    European Urology, vol. 50, no. 3, pp. 506–515, 2006
  2. MOLECULAR AND IMMUNOHISTOCHEMICAL ANALYSIS OF THE PROGNOSTIC VALUE OF CELL-CYCLE REGULATORS IN UROTHELIAL NEOPLASMS OF THE BLADDER
    European Urology Supplements, vol. 5, no. 2, pp. 77–77, 2006
  3. THE USEFULNESS OF F-18 DEOXIGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG-PET) FOR RE-STAGING RENAL CELL CANCER PATIENTS WHEN A SOLITARY METASTASIS OR AN ISOLATED RENAL FOSSA RECURRENCE IS SUSPECTED
    European Urology Supplements, vol. 5, no. 2, pp. 68–68, 2006
  4. 709Can late recurrences threaten the cancer-specific survival in patients with muscle-invasive bladder cancer included in bladder preservation programs?
    European Urology Supplements, vol. 4, no. 3, pp. 180–180, 2005
  5. RISK GROUPS IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: STATISTICAL AND CLINICAL MODEL IMPROVING HOMOGENEITY
    Journal of Urology, The, vol. 174, no. 4, pp. 1226–1230, 2005
  6. 706Outcome of a prospective study of selected patients with muscle-invasive bladder cancer treated with radical TUR alone followed for more than 15 years
    European Urology Supplements, vol. 4, no. 3, pp. 179–179, 2005
  7. Immunohistochemical Expression of Ki-67 Antigen, Cox-2 and Bax/Bcl-2 in Prostate Cancer; Prognostic Value in Biopsies and Radical Prostatectomy Specimens
    European Urology, vol. 48, no. 5, pp. 745–751, 2005
  8. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour
    BJU International, vol. 94, no. 9, pp. 1258–1262, 2004
  9. 697 Risk groups of patients with bladder cancer treated with radical cystectomy alone
    European Urology Supplements, vol. 3, no. 2, p. 177, 2004
  10. 690 Outcome of a bladder preservation program with raical TUR and systemic chemotherapy for selected patients with invasive bladder cancer. Medium-term follow-up
    European Urology Supplements, vol. 3, no. 2, p. 175, 2004
  11. The usefulness of positron emission tomography (PET) for indicating surgery in recurrent renal cell carcinoma when a solitary metastasis or an isolated renal fossa recurrence is suspected
    European Urology Supplements, vol. 2, no. 1, p. 137, 2003
  12. The role of rescue radical cystectomy (RCT) in a bladder preservation program based on tur plus chemotherapy for patients with invasive blaader cancer
    European Urology Supplements, vol. 2, no. 1, p. 128, 2003
  13. Late Oncological Occurrences Following Radical Cystectomy in Patients with Bladder Cancer
    European Urology, vol. 43, no. 5, pp. 489–494, 2003
  14. Conservative Elective Treatment of Upper Urinary Tract Tumors: A Multivariate Analysis of Prognostic Factors For Recurrence and Progression
    The Journal of Urology, vol. 169, no. 1, pp. 82–85, 2003
  15. Clinical Panurothelial Disease in Patients with Superficial Bladder Tumors: Therapeutic Implications
    The Journal of Urology, vol. 167, no. 5, pp. 2007–2011, 2002
  16. Management of nodal involvement in patients with bladder cancer
    European Urology Supplements, vol. 1, no. 1, p. 137, 2002
  17. PROSPECTIVE VALIDATION OF THE ASSOCIATION OF LOCAL TUMOR STAGE AND GRADE AS A PREDICTIVE FACTOR FOR OCCULT LYMPH NODE MICROMETASTASIS IN PATIENTS WITH PENILE CARCINOMA AND CLINICALLY NEGATIVE INGUINAL LYMPH NODES
    The Journal of Urology, vol. 165, no. 5, pp. 1506–1509, 2001